BSE filing, NSE: INSECTICID. Summary written from the filing by ALFA Finder's alert engine.
Insecticides (India) Ltd: key numbers
- Share price
- ₹512.45
- Market cap
- ₹1,491 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 11.9×Sector 34.1×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Board Meeting Date
Insecticides (India) will hold a board meeting on November 5, 2026 to consider an interim dividend for FY 2026-27. Record date is fixed as November 12, 2026.
Insecticides (India) Other Announcement
Insecticides (India) Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory disclosure.
Insecticides (India) Credit Rating
CRISIL Ratings has reaffirmed the Long-Term and Short-Term credit ratings of Insecticides (India) Limited. There is no change in the ratings assigned to the company.
Insecticides (India) Board Meeting Date
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.
Insecticides (India) Annual General Meeting
Insecticides (India) Ltd conducted its 29th Annual General Meeting on August 12, 2026. Shareholders deliberated on seven agenda items, with voting results to be disclosed later.
Insecticides (India) Earnings Call Transcript: Key Takeaways
Q1FY27 was impacted by delayed monsoons, shifting demand later. Despite revenue decline, gross margins improved due to premiumization and inventory management, though EBITDA softened on negative operating leverage.
- Call
- Guides 100% growth
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.